Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab

Published:2017-05-04 Issue:11 Volume:16 Page:1022-1028
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Cuyàs Elisabet¹²,Martin-Castillo Begoña³,Bosch-Barrera Joaquim⁴⁵^ORCID,Menendez Javier A.¹²

Affiliation:

1. Program Against Cancer Therapeutic Resistance(ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain

2. Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain

3. Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain

4. Deparment of Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain

5. Department of Medical Sciences, Medical School, University of Girona, Girona, Spain

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2017.1310353

Reference38 articles.

1. Action of RANKL and OPG for Osteoclastogenesis

2. RANKL/OPG; Critical role in bone physiology

3. Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

4. A comprehensive review of denosumab for bone metastasis in patients with solid tumors

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric research based on hotspots and frontier trends of denosumab;Frontiers in Pharmacology;2022-09-19

2. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells;Frontiers in Pharmacology;2022-08-15

3. Epidemiological Research Advances in Vascular Calcification in Diabetes;Journal of Diabetes Research;2021-10-01

4. Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review;Recent Patents on Anti-Cancer Drug Discovery;2021-05

5. Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity;Aging;2020-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3